Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.
Ratings for Vertex (NASDAQ: VERX) were provided by 7 analysts in the past three months, showcasing a mix of bullish and ...
The James Webb Space Telescope has uncovered dazzling newborn stars and thick cosmic dust in Sagittarius B2, the Milky Way's ...
Research led by a physicist at the University of California, Riverside, shows how viruses form protective shells (capsids) ...
Using a relatively young theory, a team of mathematicians has started to answer questions whose roots lie at the very ...
The U.S. Food and Drug Administration approved twice-daily JOURNAVX for the treatment of adults with moderate-to-severe acute pain on January 30, 2025. JOURNAVX is a prescription medicine used to ...